Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Nature Careers
- Umeå University
- University of Maryland, Baltimore
- Stanford University
- University of Washington
- Baylor College of Medicine
- University of North Carolina at Chapel Hill
- University of Minnesota
- Duke University
- University of Utah
- Cornell University
- Harvard University
- The Ohio State University
- University of Oslo
- University of Oxford
- VIB
- Washington University in St. Louis
- Aarhus University
- CNRS
- FAPESP - São Paulo Research Foundation
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Massachusetts Institute of Technology
- New York University
- Pennsylvania State University
- Rutgers University
- Stony Brook University
- University of Southern Denmark
- University of Virginia
- Wageningen University & Research
- Argonne
- CIML2000
- CRAG-Centre de Recerca Agrigenòmica
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Central State University
- Delft University of Technology (TU Delft)
- EURECAT
- Gustave Roussy / Inserm
- Heidelberg University
- Indiana University
- Institut Jacques Monod, CNRS UMR 7592
- Institut Pasteur
- Joseph B Sweeney
- KU LEUVEN
- King's College London
- Leibniz
- Max Planck Institute of Molecular Cell Biology and Genetics, Dresden
- Medical University of Gdańsk
- National Institute of Chemistry Slovenia
- Purdue University
- RIKEN
- Rice University
- Sanofi
- SciLifeLab
- Technical University of Denmark
- Texas A&M AgriLife
- Texas A&M University
- The University of Arizona
- The University of Western Australia
- UNIVERSITY OF HELSINKI
- Umeå universitet
- Umeå universitet stipendiemodul
- Universidade de Coimbra
- Universite de Montpellier
- University College Dublin
- University of California, Los Angeles
- University of Copenhagen
- University of Dundee;
- University of Glasgow
- University of Kentucky
- University of London
- University of Lund
- University of Luxembourg
- University of Miami
- University of Nebraska Medical Center
- University of Newcastle
- University of Oxford;
- University of Sydney
- University of Texas at Dallas
- University of Tübingen
- Vrije Universiteit Amsterdam (VU)
- Zintellect
- 71 more »
- « less
-
Field
-
deregulations involved in the development and progression of human lymphomas. The successful candidate will contribute to a research program aimed at generating, interpreting, and developing in vivo CRISPR Cas9
-
developing next‑generation CRISPR tools designed specifically for crop improvement? Then this role as research assistant might be just for you! The Laboratory of Microbiology (Wageningen University & Research
-
site-specific genome integration (e.g., CRISPR/Cas9, RMCE), next-generation sequencing, computational methods/tools for analysis, and statistics; background in molecular biology, synthetic biology
-
human health. Within this mission, the Iorio Group works at the intersection of computational biology, functional genomics, and precision oncology, integrating machine learning, large-scale CRISPR
-
proficient in epigenome-related techniques (DNA methylation and/or histone modifications) and their analysis. Alternatively, the candidate comes with an expertise in CRISPR-based epigenetic editing
-
of Biological Chemistry and Pharmacology, for a period generally not to exceed three years; performs basic science and applied research in the field of genome editing, Base editing, Prime editing, CRISPR
-
will apply include endogenous protein tagging by CRISPR and integrases, in-cell interaction proteomics by proximity labeling, subcellular localization by spatial proteomics and fluorescence microscopy
-
chromatin accessibility, CRISPR based gene and epigenetic perturbation, and deeply phenotype human cohorts to define causal mechanisms driving post infectious and post tuberculosis lung disease. Postdoctoral
-
cloning for CRISPR gene editing. The successful candidate will be expected to carry out these tasks as routine experiments, working both independently and as part of a team. The post holder will be required
-
of São Paulo (UNIFESP), in Brazil, aims to investigate how CRISPR-Cas9-mediated genetic modification of Invariant Natural Killer T (iNKT) cells can modulate their antitumor activity and therapeutic